Madrigal Pharmaceuticals Inc (NAS:MDGL) Stock News, Headlines & Updates
Madrigal Pharmaceuticals Inc Stock News from GuruFocus
- 1
Aug 15, 2024
John Paulson's Strategic Exits and Key Investments in Q2 2024: Spotlight on Newmark Group Inc
GuruFocus Research • 9:55pm
Aug 08, 2024
Madrigal Pharmaceuticals Inc (MDGL) Q2 2024 Earnings Call Transcript Highlights: Strong Rezdiffra Launch and Expanding Coverage
GuruFocus Research • 1:02am
Q2 2024 Madrigal Pharmaceuticals Inc Earnings Call Transcript
GuruFocus Research • 11:23pm
Aug 07, 2024
Madrigal Pharmaceuticals Inc (MDGL) Q2 2024 Earnings: EPS of -$7.10 Misses Estimates, Revenue of $14.64M Falls Short
GuruFocus Research • 6:33am
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Provides Corporate Updates
Marketwired • 6:00am
Aug 02, 2024
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
Marketwired • 7:00am
Jul 24, 2024
Madrigal Pharmaceuticals to Release Second-Quarter 2024 Financial Results and Host Webcast on August 7, 2024
Marketwired • 7:00am
Jun 06, 2024
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
Marketwired • 7:00am
Jun 05, 2024
Madrigal Pharmaceuticals to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Marketwired • 7:00am
May 29, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news